Although SRI-@ response rates were not significantly improved in the pooled blisibimod groups compared with placebo , they were higher in subjects randomised to the highest dose of blisibimod ( @mg once-weekly ( QW ) ) compared with pooled placebo , from Week @ to Week @ , reaching statistical significance at Week @ ( p = @ ) .